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ABSTRACT
The in vivo metabolism of orally-administered aniline (50 mg/kg) was investigated in the sheep,
the pig, and the rat. Urinary elimination in the sheep and the rat was very extensive, 80-100% of
the dose being recovered in the urine during the first 24 hr. The pig was an exception in that only
56% of the dose was eliminated during the first 24 hr. Fecal excretion of aniline in all three species
was 2% of the dose. Contrary to previous reports, N-acetylated derivatives were identified as the
major 24-hr urinary metabolites of aniline, representing 82%, 85%, and 76% of the urinary
metabolites from the sheep, the pig, and the rat, respectively. The double conjugate, N-acetyl-p-
aminophenyl glucuronide, was the major metabolite in the sheep and the pig (60% and 66%,
respectively), whereas N-acetyl-p-aminophenyl sulfate was the major metabolite in the rat
(56%). Minor urinary metabolites of aniline from these species included 0-conjugates of o- and p-
aminophenol ( 20%), acetanilide ( 3%), and N-acetyl-p-aminophenol ( 10%). N-Glucuronides
and sulfates of aniline and free aniline were not detected as urinary metabolites. In anesthetized,
ureter-cannulated rats, about 50% of a dose of aniline (25 and 50 mg/kg) was eliminated in 3 hr.
The ratio of the metabolites eliminated changed with time.
The metabolic fate of aniline was first studied
almost 100 years ago. In 1878, Schmiedeberg (1)
fed dogs with aniline acetate and identified
p-aminophenol in the urine after acid hydrolysis.
In 1887, Muller (2) studied a human case of poi-
soning by 25 g of aniline and found that the urine
reduced Fehling’s solution and contained conju-
gated p-aminophenol. Glucuronides and sulfates
of o- and p-aminophenol and some N-acetylated
derivatives have been shown to be urinary me-
tabolites in the rabbit, but the major metabolite
was a labile glucuronide (3). The nature of this
labile glucuronide, which accounted for> 50% of
the administered dose, was not established, but a
dihydroxyaniline glucuronide-type structure was
proposed. Later, it was suggested that this labile
glucuronide might be the N-glucuronide of aniline
(4). On the other hand, Parke (5), using ‘4C-ani-
line, showed that only about 3-10% of orally ad-
ministered aniline was excreted as the N-glucuro-
‘Present address: National Institute of Environmental
Health Sciences (see below).
This work was supported by Pfizer Ltd., Sandwich, Kent,
U. K. and the Science Research Council, U. K.
nide and that the major pathway of metabolism of
aniline was aromatic hydroxylation followed by
conjugation with glucuronic acid and sulfate.
The studies reported in this paper represent part
of a study to evaluate some of the major pathways
of drug metabolism and elimination in farm ani-
mals. The results obtained are compared with
those observed in the rat. Evidence is presented to
show that 0-conjugates of N-acetyl-p-aminophe-
nol are the major urinary metabolizes of aniline
and the metabolic implications of these fmdings
are discussed.
Materials and Methods
Radiochemical and Chemicals. [U-’4CIAniline hydro-
gen sulfate, 60 mCi/mmol, was obtained from The Ra-
diochemical Centre (Amersham, Bucks.) The radi-
ochemical purity was checked by thin-layer chromatog-
raphy and found to be at least 98%. Chemicals used in
liquid scintillation counting were obtained from Packard
Instruments (Caversham, Berks.) except for bis-MSB2
(Koch-Light Laboratories, Colnbrook, Bucks.), 1,4-diox-
ane (Maybridge Chemicals, Tintagel, Cornwall), and
toluene (low sulfur grade, Fisons, Loughborough, Leics.).
Chemicals and authentic metabolites used in meta-
bolic studies were of Analar grade from British Drug
Houses (Poole, Dorset) except for saccharic acid 1,4-
2Abbreviations used are: bis-MSB, p-bis(o-methyl-
styryl)benzene: PPO, 2,5-diphenyloxazole; dimethyl POPOP,
p-bis(2-(4-methyl-5-phenyloxazolyl))benzene.
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lactone, N-acetyl-p-aminophenol (Sigma, London), and
N-phenylsulfamic acid (ICN Pharmaceuticals, Horsham,
Sussex).
Enzymes used in the hydrolysis of urine samples
included Ketodase (sulfatase-free, ox liver $-glucuroni-
dase, Warner and Chilcott, Eastleigh, Hamps.), and ar-
ylsulfatase, type HI (Sigma, London).
Treatment of Animals. Details of animals used are
summarized in table I. The animals were kept in metab-
olism cages appropriate to their size. Throughout the
experiments they were allowed free access to food and
water at all times. 14C-Aniline (50 mg/kg; 100 Ci for
sheep and pigs, 5 1zCi for rats) was administered orally
as an aqueous solution in isotonic saline.
Urine was collected from the animals at regular inter-
vals during the first 24 hr after aniline administration. ln
the case of the sheep and the pig, the urine was collected
almost as soon as it was voided. All urine samples were
assayed for ‘4C immediately after collection and then
stored at -20#{176}Cuntil needed. Feces from the large
animals were collected in bags supported by a harness.
These samples were then homogenized in water, freeze-
dried, and analyzed for ‘4C by combustion.
Measurement of Radioactivity. Nuclear-Chicago Mk.
II, LKB “Wallac” 1210, and Packard Tri-Carb 3320
scintillation counters were used. Counting efficiencies
(normally 70-90%) were determined by the external
standard channels-ratio method with quench curves pre-
pared from n-[l-’4Cjhexadecane (Radiochemical
Centre), with CC!4 as the quenching agent. Quench
curves were prepared for each of the different scintillants
and counting conditions used.
Scintillation mixtures used were: I) Instagel (Packard);
2) Dioxane-based scintillant [naphthalene (60 g), PPO
(4 g), dimethyl POPOP (0.2 g), methanol (Analar) (100
ml), 1,2-ethanediol (40 ml), and 1,4-dioxane to give 1000
ml]; 3) Toluene-based scintillant EPPO (5 g), bis-MSB
(0.25 g), toluene (1000 ml)]; 4) Dioxane/toluene-based
scintillant [naphthalene (100 g), PPO (5 g), dimethyl
POPOP (0.3 g), dioxane (800 ml), toluene (200 ml)].
Urine samples and fractions of extracts from urine
(0.1-0.5 ml) were counted with scintillants 1 or 2. Freeze-
dried focal samples ( 50 mg) were combusted in a
Packard Tri-Carb oxidizer. The resultant ‘4CO2 was
trapped in ethanolamine/ethylene glycol monoethyl
ether/toluene (1:8:10, v/v) and counted in scintillant 4.
Sections of silica-gel thin-layer chromatograms were
counted in scintillant 3 containing Cab-o-Sil (5%, w/v),
whereas crystalline material from reverse isotope-dilu-
tion analysis experiments was first dissolved in di-
methylformamide (0.5 ml) and counted in scintillant 2.
In all cases, 10 ml of scintillant was used, and counting
was carried out at 4#{176}Cafter storage at 4#{176}Cin the dark
to avoid possible errors due to chemiluminescence. The
location of 4C on TLC plates was determined with a
Berthold Camlab radiochromatogram scanner.
Identification of Urinary Metabolites. Thin-layer
chromatography was carried out on silica gel 6Oiz-
precoated plates (Merck, Darmstadt, West Germany)
and silica gel G l500/LS-precoated plates (Schleicher
and Sch#{252}ll,Kassel, West Germany). Solvent system A
(table 2) was used for the chromatography of conjugated
metabolites, and system B was used for the separation of
phase I metabolites. The metabolites and reference com-
pounds were located under an ultraviolet light from a
254-nm line mercury lamp and by means of spray re-
agents. Spray reagent a and b (see table 2) are typical
reagents used for detecting free aromatic amino groups,
whereas reagent d is used for the detection of glucuro-
nides. Reagent e was used for the detection of divalent
sulfur. The location of radioactivity was determined by
using the radiochromatogram scanner and autoradiog-
raphy (Kodak blue brand medical X-ray films were
used). Autoradiography was carried out for 5-10 days
and the films were developed with Kodak Universal
developer and fixed with Kodafix in a manner recom-
mended by the manufacturer.
Enzymic hydrolysis of urine samples was performed
with /3-glucuronidase (15,000-20,000 Fishman units) and
arylsul.fatase (3000-5000 units; partially purified powder
from Helix pomatia). Saccharic acid l,4-lactone (20 mM)
was used to inhibit the /3-glucuronidase activity present
in the arylsulfatase preparation. Hydrolysis was achieved
by incubation for 16 hr at pH 5.0 in a 0.5 M acetate
buffer at 37#{176}Cin a shaking water bath. The extent of
hydrolysis of the conjugates was checked by chromatog-
raphy and subsequent autoradiography. At the end of
the incubation period, the pH of the hydrolysates was
adjusted to pH 7-8 with solid NaHCO3. The hydrolysates
were saturated with NaCl and then extracted three times
with 3 volumes of diethyl ether containing isoamyl al-
cohol (1%, v/v). Aliquots of the ether phase were dried
over anhydrous Na2SO4 and concentrated in vacuo.
These concentrated extracts were cochromatographed
with authentic metabolites. Thin-layer chromatograms
of aliquots of the aqueous phase and of the unextracted
hydrolysate were also prepared.
To identify urinary metabolites, reverse isotope-dilu-
tion analysis was employed. Authentic metabolites
(200-500 mg) were dissolved in separate portions of
TABLE I
Details of Animals













Ewe and lamb diet (Pauls Feed, Canterbury, Kent) and hay
Commercial Pig Weaner Rations (Pauls Feed)
Laboratory diet no. 1 (Spillers, Croydon, Essex)
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TABLE 2
RF values and color reactions of aniline and possible metabolites
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Chromatography solvent systems: A, 1-butanol/ethanol/glacial acetic acid/water (3:1:0.1:1, v/v); B,
chloroform/methanol/glacial acetic acid (80:20:1, v/v). Spray reagents: a, p-dimethylaminobenzaldehyde, 0.5% (w/v)
in ethanol containing concentrated HC1 (1%, v/v); b, sodium nitrate, 0.2% (w/v) in 0.1 N HC1, followed after3 mm
by ammonium sulfamate, 5% (w/v), and after a further 3 mm by aq. N-(1-naphthyl)ethylenediamine
hydrochloride, 1% (w/v); c, 0.5 N HCI followed by heating at 100#{176}Cfor 10-20 mm; d, naphthoresorcinol, 1% (w/v)
in acetone to which phosphoric acid, 10% (w/v), was added just before use (4:1, v/v), followed by heating to 140#{176}C;
e, potassium dichromate, 0.1 M in acetic acid (0.1 M), followed after 5 mm by 0.1 M silvernitrate.nd., not
determined. Dashes indicate that no color was formed.
RpValuesin Cl thS R
Solvent Systems 0 or wi pray eagen
A B a b c+a c+b d e
Aniline 0.91-1.00 0.74-0.86 nd. nd. nd. nd. - -
Acetanilide 0.94-0.98 0.72-0.76 - - - - - -
N-Acetyl-p- 0.94-0.98 0.52-0.61 - - Yellow Purple - nd.
aminophenol
o-Aminophenol 0.80-0.86 0.66-0.67 Yellow Purple Yellow Purple - nd.
m-Aminophenol nd. 0.55-0.60 Yellow Purple Yellow Purple - nd.
p-Aminophenol 0.61-0.65 0.34-0.45 Yellow Purple Yellow Purple - nd.
Phenylsulfamic 0.59-0.62 nd. nd. nd. nd. nd. nd. nd.
acid
Metabolite I 0.62-0.66 - - Yellow Purple - -
Metabolite II 0.29-0.31 - - Yellow Purple Blue -
Metabolite III 0.50-0.53 0 1 Yellow Purple Yellow Purple - -
Metabolite IV 0.12-0.15 ‘ Yellow Purple Yellow Purple Blue -
Metabolite V 0.40-0.42 Yellow Purple Yellow Purple Blue -
Metabolite VI 0.47-0.50 - - Yellow Purple - Yellow
Metabolite VII 0.91-0.94 k 0.72-0.76 - - - - - -
5 0.52-0.61 - - Pale yellow Pale purple - -
ether extracts(5-10 ml) from urine, or hydrolyzed urine.
Solvent was removed by evaporation and the residue
dried in vacuo. Acetanilide and N-acetyl-p-aminophenol
were recrystallized successively from water containing
methanol (10%, v/v) and hot water, respectively, to
constant specific radioactivity and constant melting point
(acetanilide, 114#{176};N-acetyl-p-aminophenol, 168#{176}C).Be-
fore crystallization was attempted, aminophenols were
converted to their O,N-dibenzoyl derivatives by the
Schotten and Baumann procedure (6). 0,N-Dibenzoyl-
o-aminophenol was recrystallized successively from
ethanol, ethyl acetate, and ethanol to constant specific
radioactivity and constant melting point (183#{176}C).The
O,N-dibenzoy! derivative of m-aminophenol was recrys-
tallized successively from ethanol, ethyl acetate, and
toluene to constant specific radioactivity and melting
point (153#{176}C)and the derivative of p-aminophenol was
recrystallized from methanol, ethyl acetate, and metha-
nol to constant specific radioactivity and melting point
(234#{176}C).The radioactivity associated with the crystalline
materials was monitored during reverse isotope-dilution
analysis at each stage of the recrystallization by liquid-
scintillationcounting.
Studies on Anesthetized and Ureter-cannulated Rats.
Male Wistar albino rats (250 g) were anesthetized with
sodium pentobarbital (Nembutal, Abbott Lab., Queen-
borough, Kent) and their ureters cannulated with poly-
ethylene cannula PPIO (Portex, Hythe, Kent), ‘4C-Ani-
line (5 .tCi,25 or 50 mg/kg) was administered as a
solution of its salt in isotonic saline (3-5 ml) at 37#{176}Cby
intraduodenal injection.Urine (100-200 sl) was collected
from the ureter cannulae at 15-min intervals for 3 hr and
assayed for ‘4C content. The metabolic profiles of the
samples were determined by thin-layer chromatography
of aliquots (20-40 /Ll) of urine followed by radiochro-
matogram scanning and autoradiography. The areas of
the chromatogram corresponding to the urinary metabo-
lites of aniline were located and compared with the
corresponding dark spots on the autoradiogram. These
areas were marked on the radiochromatogram, scraped
off, placed into scintillation vials, and counted as de-
scribed above. The radioactivity associated with each of
these areas was expressed as a percentage of the radio-
activity recovered from the radiochromatogram.
Results
Urinary Metabolites. Following oral adminis-
tration of ‘4C-aniline (50 mg/kg) to rats, sheep,
and pigs, more than half the dose was excreted by
each animal in 24 hr (table 3). In the rat, 96% of
the administered dose was recovered in the urine
within 24 hr, whereas in the sheep the recovery
was in the order of 80%. By contrast, only 56% of
the dose was excreted in pig urine in the first 24
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TABLE 3
Urinary metabolites of ‘4C-aniline at 50 mg/kg
G, Glucuronide; S, sulfate; NPAPG, N-acetyl-p-aminophenyl glucuronide;
sulfate; NPAP, N-acetyl-p-aminophertol; A, acetanilide; PA PG. p-aminophenylg





% of Dose % of 24-hr Excretion as
Species 24-h
Urine  S NPAPG NPAPS NPAP A PAPG
PAPS OAPG OAPS Recovery
Sheep 1 81.7 68.8 21.4 63.7 15.7 2.1 2.1 3.6 1.0 1.5 4.7 94.4
2 79.1 70.4 22.1 59.2 14.6 1.2 3.4 8.0 0.8 3.2 6.7 97.1
Pig 1 60.0 77.3 10.6 72.8 6.1 4.7 0.6 1.5 0.7 3.0 3.8 93.2
2 52.6 63.8 14.8 60.4 12.7 13.1 1.6 0.9 0.6 2.5 1.5 93.3
Rata 96.0 15.7 76.9 12.6 55.6 6.5 0.5 2.1 13.7 1.0 7.6 99.6
(87.9- (11.8- (64.0- (12.5- (51.7- (4.2- (0.4- (0.9- (12.3- (0.4- (6.6- (93.2-
101.6) 17.9) 78.6) 12.9) 60.7) 7.8) 1.0) 2.6) 16.2) 1,3) 8.4) 101.4)
a Results are expressed as the means from six animals and the ranges are given in parentheses.
hr. Between 24 and 31 hr, only a further 2% of the
dose was excreted in pig urine. Fecal excretion of
radioactivity during the first 24 hr was found to
be of the order of 2% in all three species.
The Rf values and methods of detection of
aniline, some of its possible metabolites and radio-
active components found in urine after the oral
administration of ‘4C-aniline are given in table 2.
Thin-layer chromatography followed by radi-
ochromatogram scanning of urine samples from
each species revealed the presence of several peaks.
On chromatography of rat urine, peaks I, II, and
III were detected, whereas peaks I, II, and IV were
seen in sheep urine and peaks I, II, V, VI, and VII
were observed in pig urine.
Positive naphthoresorcinol reactions were ob-
tained with peaks II, IV, and V (table 2), indicating
the presence of glucuronides. Spray reagents a and
b demonstrated that III, IV, and V contained
components with free aromatic amino groups.
When the chromatograms were first sprayed with
0.5 M HCI and heated to 100#{176}Cfor a few minutes,
a positive reaction for free aromatic amino groups
was also detected with peaks I, II, VI, and VII.
The presence of divalent sulfur was noted in area
VI ‘(spray e), indicating the possible presence of a
mercapturic acid.
Thin-layer chromatography of urine which had
been treated with /3-glucuronidase resulted in the
disappearance of the dark areas on the autoradi-
ograms corresponding to peaks II, IV, and V and
the concomitant appearance of a dark area corre-
sponding to peak VII. On the other hand, treat-
ment with arylsulfatase resulted in the disappear-
ance of dark areas corresponding to peaks I and
III and the appearance of a dark area correspond-
ing to VII. Thus, II, IV, and V are glucuronides,
whereas I and III are sulfates. Interestingly, peak
VI, which was observed only in radiochromato-
grams of pig urine, was not hydrolyzed by either
enzyme.
After ,8-glucuronidase hydrolysis of 24-hr urine
samples, 70% of the radioactivity of the hydroly-
sate of the sheep and the pig urine was extractable
with ether, whereas from the rat only 16% was
extracted. On the other hand, after arylsulfatase
hydrolysis, the ether-extractable radioactivity was
of the order of 21%, 15%, and 77% for the sheep,
pig, and rat, respectively. When the 24-hr urine
samples were incubated with 0.5 M acetate buffer
(pH 5.0) in the absence of the enzyme, the pro-
portion of radioactivity extracted under similar
conditions was 4% in the sheep,  in the rat, and
10% in the pig. These values are similar to the
proportions of radioactivity found in the ether
fractions when untreated urine from these animals
was solvent-extracted. This indicated the presence
of metabolites of aniline which are not conjugated
with glucuronic acid or sulfate.
Both qualitative and quantitative investigation
of ether extracts of hydrolysates from the enzymic
hydrolysis of urine samples by thin-layer chro-
matography, radiochromatogram scanning, and
reverse isotope-dilution analysis revealed that the
major radiolabeled component of all ether extracts
was N-acetyl-p-aminophenol. o- and p-Amino-
phenol were also present, but they accounted for
only a small proportion of the radioactivity in the
ether extract.
Analysis of ether extracts from untreated urine
samples showed that both free N-acetyl-p-amino-
phenol and acetanilide were also urinary metabo-
lites in the sheep and the pig, whereas in the rat,
free N-acetyl-p-aminophenol was found to be the
major ether-extractable metabolite. No free aniline
was detected in the urine of any animal studied.
90 120 ISO 180
Time (mm)
FIG. 1. Cumulative percentage of ‘4C excreted as
metabolites of aniline (25 mg/kg) in ureter-cannulated
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The major radiolabeled component in rat 24-hr
urine was N-acetyl-p-aminophenyl sulfate (I) and
the major labeled component of pig urine was N-
acetyl-p-aminophenyl glucuronide (II). Other
peaks were identified as p-aminophenyl sulfate
(III); p-aminophenyl glucuronide (IV), and o-ami-
nophenyl glucuronide (V). Peak VII was composed
of N-acetyl-p-aminophenol and acetanilide, and
peak VI may represent a possible mercapturic acid.
No peaks corresponding to o-aminophenyl sul-









I, N-Acetyl-p-aminophenyl sulfate; II, N-acetyl-p-
aminophenyl glucuronide; III, p-aminophenyl sulfate;
IV, p-aminophenyl glucuronide; VII, acetanilide and N-
acetyl-p-aminophenol.
tion in this case was based on enzyme hydrolysis
data and reverse isotope dilution.
m-Aminophenol, either free or conjugated, was
not found to be a metabolize of aniline by reverse
isotope-dilution analysis and the N-glucuronides
and N-sulfates of aniline were not detected.
The 24-hr urinary metabolites of orally admin-
istered aniline (50 mg/kg) which have been iden-
tified by the methods described are summarized in
table 3.
Elimination of Urinary Metabolites. Following
intraduodenal administration of ‘4C-aniline (50
and 25 mg/kg) to anesthetized and ureter-cannu-
lated rats, it was observed that at both dose levels
approximately 50% of the dose was excreted in the
urine in about 3 hr, approximately 0.5% of the
dose being detected in the urine within 15 mm of
administration. The cumulative excretion of major
urinary metabolites of aniline (25 mg/kg) is illus-
trated in fig. 1.
N-Acetyl-p-aminophenyl sulfate was identified
as the major metabolite at all time intervals but,
interestingly, maximum elimination of p-amino-
phenyl sulfate occurred at about 1 hr after admin-
istration, whereas maximum elimination of N-ace-
tyl-p-aminophenyl sulfate occurred at about 1.5 hr
after dosing.
At both the 25- and 50-mg/kg dose levels, the
elimination of the N-acetyl-p-aminophenyl sulfate
and p-aminophenyl sulfate was of the same order
initially, but as metabolism and elimination oc-
curred, the relative amount of N-acetyl-p-amino-
phenyl sulfate found in the urine increased. Con-
sequently, the relative proportions of N-acetyl-p-
aminophenyl sulfate to p-aminophenyl sulfate in
the urine 3 hr after administration was greater at
the lower dose level (see table 4).
Discussion
Aniline metabolites appeared in the urine very
rapidly following its po administration to rats,
pigs, and sheep. In the pig and the sheep, approx-
imately 30% of the administered dose was found
TABLE 4
Major urinary metabolites of ‘4C-aniline in ureter-cannulated rats 3 hr after intraduodenal administration
Results are expressed as the means from three animals and the ra nges are given in parentheses. A bbreviations are




NPAPS PAPS NPAPG PAPG NPAP
+A
mg/kg
25 50.2 34.9 10.7 3.1 0.4 1.5
(48.6-50.8) (34.2-35.4) (10.1-11.1) (2.8-3.6) (0.3-0.9) (1.3-2.2)
50 47.0 25.0 15.1 3.3 1.0 1.9
(43.8-52.3) (22.1-27.6) (13.2-16.1) (2.9-3.8) (0.5-1.8) (1.3-2.2)
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in the urine 3 hr after administration, whereas in
ureter-cannulated rats at a dose of 25 or 50 mg/kg,
approximately 50% of the dose of aniline was
eliminated in the urine in about .3 hr. Aniline is
lipophilic, with a pKa of 4.6, and would be cx-
pected to be rapidly and completely absorbed from
the small intestine (7). Fecal radioactivity was very
low and urinary recoveries of radioactivity were
generally high, supporting this view. The absence
of free aniline in the urine of any of the species
studied suggests that distribution and metabolism
are the limiting factors in the rate of elimination
of orally administered aniline.
The major urinary metabolites of aniline found
in the rat, pig, and sheep were glucuronic acid and
sulfate conjugates of N-acetyl-p-aminophenol. In-
terestingly, N-acetyl-p-aminophenol is the phar-
macologically active compound acetaminophen
(paracetamol) and the possible synthesis of this
compound by acetylation followed by hydroxyl-
ation during the metabolism of aniline may be an
example of oxidation and conjugation reactions
causing in vivo drug activation.
Species differences were observed in the urinary
excretion of orally administered aniline. Thus, in
the rat, sulfate conjugates were the major metabo-
lites (77%), whereas in the sheep and the pig, major
metabolites were glucuronic acid conjugates
(70%). However, N-acetylation was found to be
the major conjugation pathway in the metabolism
of aniline at 50 mg/kg in these species. Urinary
metabolites of aniline which were N-acetylated
accounted for 82%, 85%, and 76% in the sheep,
pig, and rat, respectively.
Direct conjugates of aniline other than acetani-
lide, such as the labile N-glucuronide and phen-
ylsulfamic acid, were not detected as urinary me-
tabolites. This is unlikely to be a result of their
hydrolysis on standing in urine or following chro-
matography because no free aniline was observed
despite the great care to avoid it being volatilized.
The results obtained from the present in vivo
investigations fail to confirm previous observa-
tions that the principal urinary metabolite of ani-
line is either the glucuronic acid or sulfate conju-
gate of aminophenols (5) or the acid labile N-
glucuronide (3, 4). A common feature in previous
investigations was the use of relatively strong acids
to hydrolyze the glucuronic acid- and sulfate-con-
jugated metabolites to their phase I metabolites in
order to identify them. Such hydrolytic procedures
could also lead to the deacetylation of any N-
acetylated derivatives of aniline present as urinary
metabolites. This was demonstrated when an
aqueous solution of N-acetyl-p-aminophenol was
boiled with 6 N HC1 for 1 hr, subsequent thin-
layer chromatography showed the appearance of
p-aminophenol.
In the present investigation, enzymic sulfate and
glucuronide hydrolysis under much milder hydro-
lytic conditions than those previously used was
employed and the chemical environment of the
enzymic experiments was such that in the absence
of enzymes, no significant chemical hydrolysis
appeared to occur. A further explanation for the
differences between the previously reported met-
abolic profiles of aniline and the present results is
the difference in the dose levels used. In earlier
experiments with the rabbit and the rat, the dose
levels ranged from 200 to 500 mg/kg, at which
signs of aniline toxicity are often seen (3, 5, 8),
compared with the 50-mg/kg dose used in the
present work. At these higher dose levels, it is
possible that either the acetylation pathway is
saturated, or enzymic deacetylation of the prod-
ucts of the acetylase enzyme is extensive due to
“activation” of deacetylase by high levels of acetyl
derivatives. Either or both events would entail that
on the basis of the percentage of the dose, metabo-
lites excreted as acetyl derivatives will be lowered.
Indeed, our studies in ureter-cannulated rats have
shown that increasing the dose decreases the rela-
tive amount of N-acetyl derivative excreted in the
urine.
No work appears to have been reported on the
relationship between N-acetylation and N-dea-
cetylation reactions at different dose levels. How-
ever, some investigations in the rat on the in vivo
deacetylation of acetyl derivatives of sulfanilamide
(9) and of a number of [acetyl-’4CJ acetanilides
(10) have been conducted. This suggests that a
considerable amount of N-deacetylation can occur
and that the products may subsequently undergo
some reacetylation.
The pig differed from the sheep and rat in a
number of respects. In the sheep and the rat,
80-90% of the dose was eliminated in 24 hr;
whereas in the pig, about 56% of the dose appeared
in the urine in the same period. Excretion via the
fecal route did not account for this discrepancy. A
particular feature of the metabolite profile in the
urine of the three species was that the percentage
of the dose excreted as a sulfate conjugate was
very much lower in the pig. The slower excretion
of aniline metabolites in the pig may partially
reflect this inability for sulfation of the phase I
metabolite. It is known that the pig is deficient in
its ability to sulfate conjugate a number of other
xenobiotics (11-13).
An unidentified sulfur-containing metabolite
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(VI) was observed in the pig but not in the sheep
or rat. This metabolite was not hydrolyzed by /‘I-
glucuronidase or arylsulfatase, but gave a positive
reaction with potassium dichromate/silver nitrate
spray reagent (14), which indicated the presence
of divalent sulfur atoms. This metabolite may be
a mercapturic acid. Indeed, inasmuch as N-acetyl-
p-aminophenol was identified as the major metab-
olite in the present investigation, and because
Mitchell et a!. (15) have shown that acetamino-
phen can interact with glutathione to form a read-
ily excreted mercapturic acid, this unknown me-
tabolite may be the mercapturic acid derived from
N-acetyl-p-aminophenol conjugation with gluta-
thione. Although unambiguous identification of
this metabolite has yet to be completed, its chro-
matographic properties are consistent with its ten-
tative identification as the N-acetylcysteme con-
jugate of N-acetyl-p-aminophenol.
o- and p-Hydroxylation to give aminophenols is
an important pathway in the metabolism of ani-
line. As the relative proportion of these phenols is
subject to species variation, Parke (5) suggested
that two aniline hydroxylases are responsible for
the synthesis of the two isomeric phenols and that
the relative activities of these enzymes vary from
species to species, thus giving rise to a possible
explanation for the observed species differences in
o- and p-hydroxylated metabolites of aniline (11).
In the present investigation, urinary o-hydroxyl-
ated metabolites of aniline in the three species
accounted for about 4-10% of the urinary metabo-
lites. This suggests that aniline 2-hydroxylase ac-
tivity in these species is very low compared to that
of aniline 4-hydroxylase. However, inasmuch as it
has been demonstrated that N-acetyl derivatives
constitute the major metabolites of aniline in these
species, it is possible that the production of the
isomeric phenols may be influenced by the acety-
lation of aniline. Because N-acetylation of aniline
may occur prior to ring hydroxylation and the
acetanilide so formed is likely to be preferentially
p-hydroxylated, it is apparent that the relative
amount of o- and p-hydroxylation may be related
to the extent to which aniline is acetylated prior to
exposure to the hydroxylation enzyme. Indeed, the
extent of this N-acetylation may be an important
factor in determining species differences in o- and
p-hydroxylation of aniline and clearly merits fur-
ther investigation.
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